FDA Names Facilities that Recieved Medications from NECC
Learn More About This Topic: Chat with Us | Email Us
PUBLICATION: KJRH-NBC Tulsa
DATE PUBLISHED: 10/25/12
TULSA - The Food and Drug Administration has released a list of medical facilities across the country that received shipments of the injectable steroid linked to the deadly meningitis outbreak.
There is also new information about the conditions at the Massachusetts pharmacy that produced it.
The FDA says six facilities in Tulsa, including Cancer Treatment Centers of America, have received shipments of medication from the New England Compounding Center.
Still, the FDA is urging any health care providers who received any medication from the pharmacy to pull those shipments and set them aside.
The Tulsa Health Department says meningitis-infected medicine is very rare.
There are no reported cases in Oklahoma. Epidemiologist Kelly Vanbuskirk said if a patient has a concern, "we refer them to their doctor. Their doctors are the ones that are going to know
if they have received products. At this time, we don't have any information it's been sent to Oklahoma."